Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry

Citation
Wittbrodt E, Chamberlain D, Arnold SV, et al. Diabetes Obes Metab 2019;21:1985–9.